Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in FBIO — Fortress Biotech, Inc.

CIK 886982 NEW YORK, NY
Back to FBIO Full portfolio

Position in FBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$294,855
+$273,222 QoQ
Shares Held
96,358
+728.5% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 55 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. FBIO ranks #307 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in FBIO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $294,855 96,358
2025-06-30 $21,633 11,631
2025-03-31 $20,326 13,030
2024-12-31 $26,059 12,837
2024-03-31 $23,828 11,914
2023-12-31 $32,577 10,823
2023-09-30 $47,410 163,484
2023-06-30 $89,628 162,961
2023-03-31 $137,202 167,320
2022-12-31 $108,238 163,997
2022-09-30 $140,736 163,647
2022-06-30 $156,758 186,618
2022-03-31 $344,046 252,976
2021-12-31 $578,717 231,487
2021-09-30 $756,451 234,923
2021-06-30 $670,381 187,782
2021-03-31 $796,558 225,654
2020-12-31 $396,439 125,060
2020-09-30 $626,389 155,047
2020-03-31 $307,090 162,482